• 전력전자학회:학술대회논문집
• /
• 전력전자학회 2008년도 하계학술대회 논문집
• /
• pp.136-138
• /
• 2008

The output voltage of synchronous generator is regulated constantly by field current control in excitation system. Most of ship generator exciter system uses the thyristor phase controlled rectifier. However this rectifier is difficult to realize that the speed control system because its control period is slower than MOSFET and IGBT type converter. Therefore, this paper deals with PMG(Permanent Magnet Generator) type digital excitation system using MOSFET for ship synchronous generator. The organization of this excitation system is very simple. When the generator is under the short circuit accident, the output voltage becomes zero state and AVR can not operate. Thus generator requires the function for flowing output current through CBS. The performance of the proposed system is evaluated on a 10kVA experimental prototype circuit in place of real ship generator.

• 한국태양에너지학회 논문집
• /
• 제35권6호
• /
• pp.1-7
• /
• 2015

This paper deals with the design and operation of a hybrid daylighting system that uses natural and artificial lighting to enhance visual comfort in buildings. The system was developed using an AVR micro controller for solar tracking in conjunction with dimming controls, which, acting together, enables the maximum use of natural daylight and also improves energy efficiency in buildings. Experimental results clearly demonstrates the usefulness of the present system capable of enhancing indoor lighting conditions when sufficient daylight is available and distributed appropriately in harmony with artificial lighting.

• 말소리와 음성과학
• /
• 제6권4호
• /
• pp.181-187
• /
• 2014

The present study was performed to investigate the characteristics of breath groups while reading paragraph in normal adults and adult patients with voice disorders. 10 normal females(avr. 20.6 yrs.), 10 young voice disorder females(avr. 33.5 yrs., P1 group), and 10 old voice disorder females(avr. 56.3 yrs., P2 group) read a paragraph of 210 syllables. By using the 'Running Speech' program of the Phonatory Aerodynamic System(PAS), total duration, numbers of breath groups, duration per breath group, and numbers of syllables per breath group were measured, and their correlations with aerodynamic measurement results of reading were analyzed. As a result, in total duration, numbers of breath groups, normals scored highest and P2 group speakers, lowest. Normals showed the longest duration per breath group which was not significant. P2 group speakers showed the highest numbers of syllables per breath group. Correlation analysis showed significantly high correlation scores of total duration and expiratory airflow; numbers of breath groups and inspiratory volume.

• 대한전기학회:학술대회논문집
• /
• 대한전기학회 2008년도 제39회 하계학술대회
• /
• pp.2315-2316
• /
• 2008

본 논문에서는 Multi-stage 코일건의 동작시간에 따른 성능향상 및 솔레노이드의 최적화에 대해 연구하였다. 동일한 저항값을 가진 솔레노이드에 자기차폐효과를 적용시켜 최적화된 솔레노이드 형상을 설계하였으며, 이 솔레노이드 3개를 이용해 Multi-stage 코일건을 제작하였다. 제작된 Multi-stage 코일건의 성능 향상을 위해 본 논문에서는 AVR(ATmaga128)을 이용하여 각 솔레노이드의 동작시간을 제어하고 Multi-stage 코일건의 각 동작시간에 따라 발사체의 속도가 증가한다는 것을 측정값을 통해 검증하였다.

• Journal of Chest Surgery
• /
• 제28권12호
• /
• pp.1122-1131
• /
• 1995

One hundred eighty-eight patients[August.23,1988,through July.30,1994 underwent aortic[AVR , mitral[MVR , or double [DVR valve replacement with the St.Jude Medical prosthesis. The author analyzed 100 patients with valvular heart disease,who underwent valve replacement with the St.Jude Medical prothesis from 1990 to 1994, at Hanyang University hospital Cardiovascular department. Information on volume and functional change of the heart chamber can be obtained by cardiac echocardiography and cartheterization. Out of 100 patients, 40 patients were male[40% and 60 patients were female [60% . Age ranged from 13 years to 68 years, with mean age of 42.6 years. Mean height was 160.3cm and mean body weight was 54.9Kg. According to NYHA functional classification, class III is most frequent and 60 patients could be classfied under it. MVR [involved Redo MVR was performed in 40 patients, AVR [involved Redo AVR was performed in 18 patients, and DVR [involved Redo DVR was performed in 42 patients. Warfarin [Coumadin anticoagulation was recommended for all patients. Life long warfarin anticoagulation was necessary to all patients who underwent valve replacement with St.Jude Medical prosthesis. Ideal prothrombin time was maintained about 30% during warfarinization. There were no case of mechanical failure. It followed a comparison of echocardiography before and after valve replacement at Hanyang University hospital [30 patients and a preoperative evaluation of cardiac catheterization and angiography [64 patients . The St.Jude Medical cardiac valve is a viable alternative in the surgical therapy of valvular heart disease.

• Journal of Magnetics
• /
• 제19권2호
• /
• pp.197-204
• /
• 2014

A transcranial magnetic stimulation device is a complicated appliance that employs a switching power device designed for discharging and charging a capacitor to more than 1 kV. For a simple transcranial magnetic stimulation device, this study used commercial power and controlled the firing angle using a Triac power device. AC 220V 60 Hz, the power device was used directly on the tanscranial magnetic stimulation device. The power supply device does not require a current limiting resistance in the rectifying device, energy storage capacitor or discharge circuit. To control the output power of the tanscranial magnetic stimulation device, the pulse repetition rate was regulated at 60 Hz. The change trigger of the Triac gate could be varied from $45^{\circ}$ to $135^{\circ}$. The AVR 182 (Zero Cross Detector) Chip and AVR one chip microprocessor could control the gate signal of the Triac precisely. The stimulation frequency of 50 Hz could be implemented when the initial charging voltage Vi was 1,000 V. The amplitude, pulse duration, frequency stimulation, train duration and power consumption was 0.1-2.2T, $250{\sim}300{\mu}s$, 0.1-60 Hz, 1-100 Sec and < 1 kW, respectively. Based on the results of this study, TMS can be an effective method of treating dysfunction and improving function of brain cells in brain damage caused by ischemia.

• Journal of Plant Biotechnology
• /
• 제32권2호
• /
• pp.73-83
• /
• 2005

Disease resistance in plants is often controlled by gene-for-gene mechanism in which avirulence (avr) gene products encoding by pathogens are specifically recognized, either directly or indirectly by plant disease resistance (R) gene products and sequential signal transduction pathways activating defense responses are rapidly triggered. As a results, not only exhibit a resistance against invading pathogens but also plants maintain the systemic acquired resistance (SAR) to various other pathogens. This molecular interaction between pathogen and plant is commonly compared to innate immune system of animal. Recent studies arising from molecular characterization of a number of R genes from various plant species that confer resistance to different pathogens and corresponding avr genes from various pathogens resulted in the accumulation of a wealth of knowledge on molecular mechanism of gene-for-gene interaction. Furthermore, new technologies of genomics and proteomics make it possible to monitor the genome-wide gene regulation and protein modification during activation of disease resistance, expanding our ability to understand the plant immune response and develop new crops resistant to biotic stress.

• 정보처리학회논문지:컴퓨터 및 통신 시스템
• /
• 제9권5호
• /
• pp.107-112
• /
• 2020

초 경량암호 CHAM은 자원이 제한된 장치 상에서 효율성이 뛰어난 덧셈, 회전연산, 그리고 XOR 연산으로 이루어진 알고리즘이다. CHAM은 특히 사물인터넷 플랫폼에서 높은 연산 성능을 보인다. 하지만 사물 인터넷 상에서 사용되는 경량 블록 암호화 알고리즘은 부채널 분석에 취약할 수 있다. 본 논문에서는 CHAM에 대한 1차 전력 분석 공격을 시도하여 부채널 공격에 대한 취약성을 증명한다. 이와 더불어 해당 공격을 안전하게 방어할 수 있도록 마스킹 기법을 적용하여 안전한 알고리즘을 제안하고 구현 하였다. 해당 구현은 8-비트 AVR 프로세서의 명령어셋을 활용하여 효율적이며 안전한 CHAM 블록암호를 구현하였다.

• Journal of Chest Surgery
• /
• 제17권2호
• /
• pp.223-230
• /
• 1984

Since January 1977 to the end of September 1982, total 60 Ionescu-Shiley pericardial xenograft heart valves were implanted for valve replacement in 50 patients at the Han Yang University Hospital. The operative procedures were as follow: Mitral valve replacement [MVR] in 25 patients, Mitral valve replacement [MVR] and Tricuspid valve [TV] annuloplasty in 7 patients, Aortic valve replacement [AVR] in 8 patients, Aortic valve replacement [AVR] and Mitral valve replacement [MVR] in 8 patients. Aortic valve replacement [AVR] and Mitral valve replacement [MVR] and Tricuspid valve [TV] annuloplasty in 2 patients. To evaluate the immediate hemodynamic changes after valve replacements, the pressures of each cardiac chamber and ulmonary artery were checked before and after valve replacement on the operation table. Right ventricle [RV] pressure was decreased from 52.09\ulcorner6.71 to 45.57\ulcorner5.03 mmHg, Pulmonary artery [PA] pressure was decreased from 45.97\ulcorner2.69 to 41.00\ulcorner3.99 mmHg, and Left atrium [LA] pressure was decreased from 30.33\ulcorner13.02 to 22.76\ulcorner.97 mmHg before and after valve replacement. In MVR group, RV pressure was decreased from 49.17\ulcorner7.89 to 43.14\ulcorner4.14 mmHg, PA pressure was decreased from 44.67\ulcorner3.18 to 38.67\ulcorner2.85 mmHg, and LA pressure was decreased from 31.46\ulcorner13.47 to 21.91\ulcorner.17 mmHg. In AVR group, RV pressure was decreased from 53.0\ulcorner7.44 to 44.71 \ulcorner3.24 mmHg, PA pressure was decreased from 34.83\ulcorner0.73 to 31.86\ulcorner.36 mmHg, and LA pressure was not changed. In double valve replacement [MVR and AVR] group, RV pressure was decreased from 57.50\ulcorner3.82 to 42.50\ulcorner.80 mmHg, PA pressure was decreased from 51.17\ulcorner1.42 to 43.33\ulcorner4.53mmHig, and LA pressure was decreased from 34.33\ulcorner2.09 to 25.50\ulcorner0.21 mmHg. But in the group where MVR and TV annuloplasty were performed, preoperative RV and PA pressure were markedly increased and no pressure decrease in RV and PA noticed after valve replacement. This study shows good immediate postoperative hemodynamic results after valve replacement using Ionescu-Shiley xenograft valve except in the cases of MVR and TV annuloplasty and advanced disease with pulmonary hypertension.

• Journal of Chest Surgery
• /
• 제16권4호
• /
• pp.602-614
• /
• 1983

Six hundred fourteen consecutive cases of bioprosthetic cardiac valve replacement performed during the period from March 1976 through December 1982 were reviewed. A total of 748 tissue valves [534 Ionescu-Shiley valves, 144 Hancock valves, 46 Angell-Shiley, and 24 Carpentier-Edwards] were implanted in 610 patients. Of these, 477 had single valve replacements [403 mitral, 60 aortic, and 14 tricuspid] including three REDO MVR and one REDO AVR. The remaining 129 had double valve replacements [95 AVR and MVR and 34 MVR and TVR] and 8 had triple valve replacement.592 cases were evaluated. Overall early mortality rate [within 30 days of operation] was 7.1% [6.2% in single valve replacement, 10.2% in double valve replacement, and 16.7% in triple valve replacement]. Leading causes of mortality were low cardiac output or myocardial failure and ventricular arrhythmias. The follow-up period was from one month to 7 years with a cumulative follow-up of 906.6 patient-years [mean 1.53 years]. The late mortality was 1.6%, 3.9%, 0%, 2.6%, 6.6% and 2.0% per patient-year for MVR, AVR, TVR or triple valve replacement, AVR+MVR, MVR+TVR and total, respectively. Actuarial analysis of late results including early mortalities indicates an expected survival rate of 87.6+1.8% at 3 years and 85.92.4% at 7 years for all cases. We also analyzed actuarial survival rate between groups of each valve replacement [AVR, TVR, Double valve, and Triple valve] and the tissue valve groups in MVR. We experienced 7 cases [0.77% per patient-year] of confirmed endocarditis, two of which were fatal. Valve failure-free rates calculated according to the confirmed cases were 97.5% at 4 years, 87.5% at 7 years, and 88.3% at 6 years for Ionescu-Shiley, Hancock and Angell-Shiley valves, respectively. The occurrence rate of thromboembolism was 2.0% per patient-year in total cases, although almost all the patients were given anticoagulant therapy for one year. The occurring rate in MVR was 1.5% and 2.7% per patient-year for Ionescu-Shiley and Hancock valve groups, respectively. The difference in actuarial rate free from thromboemboli between Ionescu-Shiley and Hancock groups was statistically significant [P value less than 0.001]. Thromboembolic events beyond the period of anticoagulation therapy mainly occurred in patients with atrial fibrillation. The actuarial thromboemboli free survival was 95.71.4% at 3 years and 80.17.3% at 7 years. The incidence of hemorrhagic complications was 1.2% per patient-year [fatality 0.55% per patient-year] for anticoagulated patients. Although our clinical data favorably compares with results from other reports, our results suggest that anticoagulant therapy be given on a short-term basis or not at all to hemodynamically stable patients. Long-term therapy with antiplatelet drugs is probably inevitable with patients who have thromboembolic risk factors [such as atrial fibrillation].